As Pharmacy Technician Day approaches, the CEO of the Pharmacy Technician Certification Board argues that real recognition means career ladders, consistent scope regulations, and investment in certification.
|Articles|March 7, 2020
- March 2020
- Volume 88
- Issue 3
Continuing Education: Examining Best Practices for Specialty Pharmacists to Improve the Care of Patients with α1-Antitrypsin Deficiency
Examining Best Practices for Specialty Pharmacists to Improve the Care of Patients With α1-Antitrypsin Deficiency
Advertisement
Faculty
Mark A. Malesker, PharmD, FCCP, FCCM, FASHP, BCPS, Professor of Pharmacy Practice and Medicine at Creighton University in Omaha, Nebraska
Lee E. Morrow, MD, FCCP, ATF, MSc, Professor of Medicine in the Division of Pulmonary and Critical Care at Creighton University, Chief of Pulmonary and Critical Care at Nebrasks-Western Iowa VA Medical Center in Omaha, Nebrasksa
At the completion of this activity, the participant will be able to:
- Explain the hereditary basis, pathophysiology, and diagnostic challenges of α1-antitrypsin deficiency (AATD)
- Investigate the available therapies for AATD by understanding key characteristics including mechanism of action and efficacy
- Examine the dosing, preparation, and administration of available therapies for AATD Identify key counseling points for effective communication with patients receiving augmentation therapy for AATD
Target Audience: Pharmacists
Activity Type: Application
Release Date: December 20, 2019
Expiration Date: June 15, 2021
Esimated Time to Complete Activity: 2 hours
Fee: This lesson is offered for free at
Articles in this issue
over 6 years ago
Interactives: Case Studies (March 2020)over 6 years ago
Medication Therapy Management Can Boost Adherenceover 6 years ago
Become Familiar With the False Claim Actover 6 years ago
Considerations of Claritin-D® for Nasal Allergy Symptom Reliefover 6 years ago
Standard Insulin Pen Needles Require CautionAdvertisement
Related to this article
William J. Peppard, PharmD, explains how emerging suzetrigine findings after knee arthroplasty connect opioid stewardship with functional recovery and the pharmacist’s role in ensuring treatment access.
Tor Härnqvist, MD, discusses immune testing after invasive pneumococcal disease, serotype-informed vaccine selection, and pharmacists' role in supporting patients on immunoglobulin therapy.
In adults with type 2 diabetes at high cardiovascular (CV) risk, the oral GLP-1 RA also improved HbA1C and weight, with less hypoglycemia but more GI events.
In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.
BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1C by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Butter, Beef Tallow, and LDL: Where Dietary Guidelines Diverge
2
Why Patients Fear Statins Will Affect Their Memory
3
Orforglipron Shows CV Safety vs Insulin Glargine in ACHIEVE-4
4
Suzetrigine After Knee Replacement: Are Fewer Opioid Prescriptions Enough?
5